SAMRAT PHARMACHEM
|
The Current P/E Ratio of SAMRAT PHARMACHEM is -38.19.
| Share Price | ₹206.5 | Apr 02,2026 |
| Market Cap | ₹64.0 Cr | |
| Earnings-TTM | ₹-1.7 Cr | TTM-Standalone Results |
| Price/Earnings | -38.19x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of SAMRAT PHARMACHEM
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹64.0 Cr] as on Apr 02,2026
(/) Earnings [ ₹-1.7 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ -38.19x ]
Thus, for SAMRAT PHARMACHEM , the investors are currently willing to pay -38.19 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SAMRAT PHARMACHEM !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SAMRAT PHARMACHEM over the last five years.
Historical PE (Price/Earnings) ratio chart of SAMRAT PHARMACHEM
PE Ratio Performance Analysis for SAMRAT PHARMACHEM
- SAMRAT PHARMACHEM 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 16.94x.
- SAMRAT PHARMACHEM 's operated at median p/e ratio of 8.72x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SAMRAT PHARMACHEM 's p/e ratio peaked in Mar2024 at 47.64x.
- SAMRAT PHARMACHEM 's p/e ratio hit its five-year low in Mar2023 of 6.89x.
How does SAMRAT PHARMACHEM 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| SAMRAT PHARMACHEM | -1.68 | -38.19 | 64.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 36.96 | 406,603.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 62.72 | 155,485.0 |
| CIPLA LTD | 4,544.70 | 21.21 | 96,400.8 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 59.42 | 135,009.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 18.45 | 101,628.0 |
| MANKIND PHARMA LTD | 1,796.65 | 45.90 | 82,460.4 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 17.63 | 86,963.8 |
| LUPIN LTD | 4,669.18 | 22.29 | 104,091.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 22.09 | 77,592.2 |
| ABBOTT INDIA LTD | 1,524.13 | 36.63 | 55,833.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SAMRAT PHARMACHEM 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | -38.19x |
| Max industry PE | 62.72x |
| Median industry PE | 22.29x |
| Average industry PE | 27.74x |
You may also like the below Video Courses